Navigation Links
Transcend Medical Expands Leadership Team Appointing Chief Medical Officer and Vice President of Clinical Affairs
Date:8/31/2009

MENLO PARK, Calif., Aug. 31 /PRNewswire/ -- Transcend Medical, Inc., an ophthalmic device company dedicated to delivering breakthrough advances in the treatment of glaucoma, today announced that it has filled two key positions with the addition of Sean Ianchulev, MD, as Chief Medical Officer and Ginger Clasby as Vice President of Clinical Affairs.

Dr. Ianchulev joins the company from Genentech, Inc where he was the group medical director for the ophthalmology division and the Lucentis franchise. In his role, he headed clinical development and medical affairs activities and was instrumental to the launch and success of Lucentis - a multi-billion dollar bio-therapeutic for the treatment of age-related macular degeneration. Dr. Ianchulev also has deep experience with medical devices. As the founder of the Peristat Group, Inc., he developed the first diagnostic device for remote telemonitoring of visual function and disease management of patients with glaucoma and macular degeneration

Dr. Ianchulev received his medical degree and a master's of public health from Harvard University and completed his specialty training at the Doheny Eye Institute, University of Southern California. As a practicing ophthalmic surgeon and glaucoma specialist, he is well published in the field of ophthalmology and currently serves as an Assistant Clinical Professor of Ophthalmology at the University of California at San Francisco (UCSF).

Ms. Clasby is a seasoned medical device executive with varied, in-depth experience in clinical affairs, operations, quality assurance, and marketing. As an effective leader in both start-ups and large corporate environments, she brings critical knowledge and industry experience gained from more than 15 years serving executive level positions in operations and business development with Promedica International, a contract research organization. At Promedica International, she spearheaded the growth of the clinical regulatory division, establishing the company as a respected, major provider of clinical research services within the ophthalmic and medical device market sectors. Previously she served as Vice President, Marketing and Sales at Optical Radiation Corporation and began her career with nearly a decade of experience at Allergan Medical Optics.

"Ginger and Sean offer us the breadth and depth of relevant experience and leadership skills needed to further develop the Transcend Cypass(TM) System as a therapeutic device to address glaucoma," said Brian Walsh, President and Chief Executive Officer of Transcend Medical. "Their hires come at a critical time of growth as we embark on our pivotal clinical trial."

The Transcend CyPass System is a minimally invasive procedure developed as an alternative or adjunct to chronic, life-long medication therapy for a more effective and convenient treatment for glaucoma. Transcend Medical is validating its novel, proprietary system for the sustained reduction of intraocular pressure (IOP).

About Transcend Medical, Inc.

Transcend Medical (www.transcendmedical.com) focuses on the research and development of medical devices for the treatment of glaucoma, the leading cause of adult irreversible blindness. It is estimated that nearly four million people in the U.S. and 70 million worldwide are afflicted with the disease today and the numbers are expected to grow to nearly six million in the U.S. and to over 80 million worldwide by the year 2013. Based in Menlo Park, Calif., Transcend Medical was the first company to be spun out of ForSight Labs (www.forsightlabs.com), an incubator solely focused on ophthalmic innovations.


'/>"/>
SOURCE Transcend Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Transcend Medical Raises $35 Million Series B Round Towards Development of Novel Glaucoma Treatment
2. Life Extension Book, TRANSCEND, Hits Bookstores Today
3. Transcending politics to save lives
4. Transcendental Meditation buffers students against college stress: Study
5. Transcend Medical Announces New President and CEO and Appointment of Chairman of the Board
6. Transcendental meditation effective in reducing high blood pressure, study shows
7. Patients of Courage Transcend Physical Disfigurement, Help Others
8. ReBuilder Medical Technologies, Inc.s Dr. Phillips to Speak to Ohio Investment Group
9. PLC Medical Systems to Demonstrate RenalGuard(R) at ESC 2009
10. Former Veterans Affairs Secretary Joins Integrated Medical Systems Advisory Board
11. Provider of Diabetes Medical Supplies Receives 2009 Best of Boca Raton Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... 28, 2017 , ... Revolution for Truth has organized the ... parental rights and civil liberties, and to restore transparency within government agencies responsible ... with a press conference taking place Friday morning calling on President Trump to ...
(Date:3/28/2017)... ... ... Dr. Isabella Wentz, PharmD, FASCP, one of the leading thyroid experts of ... Dr. Wentz talked about journey and research recently on a blog and discussed some ... only solution to deal with thyroid disease. , Dr. Wentz completed her graduation ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... software and services, is proud to announce it has joined the National Association ... representing the interests of chronically ill, disabled, and dying Americans of all ages ...
(Date:3/28/2017)... Pittsburgh, PA (PRWEB) , ... March 28, 2017 ... ... built for and by physicians, announced today the launch of a free, public-facing ... The Via Cost Analyzer (VCA) was developed to provide comparative information to patients, ...
(Date:3/28/2017)... ... March 28, 2017 , ... Z-Medica, LLC, ... of Pittsburgh Medical Center (UPMC) will acquire QuikClot® Bleeding Control Kits® (BCK) to ... developed in association with efforts by the American College of Surgeons, U.S. Department ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... , United Kingdom and  BOSTON , March ... provider Linguamatics today announced a partnership ... . The agreement allows pharmaceutical companies to extract ... I2E text mining technology. ... 18 of the top 20 global pharmaceutical companies. ...
(Date:3/28/2017)... Calif. , March 28, 2017  AcelRx ... focused on the development and commercialization of innovative ... announced that the European Medicines Agency (EMA) has ... tablet, 30 mcg) Marketing Authorisation Application (MAA) has ... the MAA is underway. The MAA for ARX-04 ...
(Date:3/28/2017)... -- The global flow cytometry market ... 2025, according to a new study by Grand View ... cancer is expected to upsurge the demand for flow ... years. In addition, higher number of physicians is inclined ... therapy, due to adverse effects caused by chemotherapy & ...
Breaking Medicine Technology: